The periconceptual environment represents a critical window for programming fetal growth trajectories and susceptibility to disease; however, the underlying mechanism responsible for programming remains elusive. This study demonstrates a causal link between reduction of precompaction embryonic mitochondrial function and perturbed offspring growth trajectories and subsequent metabolic dysfunction.
INTRODUCTION
Evidence in both animal models and humans has demonstrated that the environment surrounding the preimplantation embryo not only can influence the capacity to produce a viable pregnancy but, more significantly, also can impair the growth trajectory of the subsequent fetus. For example, a rodent model of maternal low-protein diet, fed specifically during the preimplantation period, produced offspring with increased risk of cardiovascular disease and behavioral dysfunction [1] . Furthermore, culture of human preimplantation embryos in different culture media during in vitro fertilization (IVF) treatment can alter the birth weight curve, which is evident as early as the second trimester [2, 3] , and children resulting from IVF treatment have been reported to have lower birth weight, altered body fat composition (with higher peripheral skinfolds, peripheral body mass, percentage of peripheral body fat, and total body fat levels), and increased blood pressure compared to children who were spontaneously conceived [4] [5] [6] . These studies suggest that the early preimplantation embryo is susceptible to environmental cues that can induce developmental programming. However, the underlying mechanism for how this periconceptual programming of offspring health occurs is unknown.
Suboptimal culture conditions for the oocyte and embryo, such as simple culture medium [7] , high oxygen concentrations [8] , suboptimal pH [9] , increased ammonium [10, 11] , addition of substrates of serum to culture media [12] , and absence of key substrates, including amino acids and vitamins [13, 14] , manifest in slower rates of embryo development, poor blastocyst formation, and loss of viability after transfer to recipient mothers. One common finding from these studies is a loss of preimplantation embryonic metabolic control (reduced ATP, increased reactive oxygen species [ROS] , and impaired mitochondrial membrane potential [MMP] ), implicating metabolic function as a key mediator for embryonic success. Impaired embryonic mitochondrial function is not limited to in vitro conditions; dietary intake (including high-and lowprotein diets) [15, 16] , obesity [17] [18] [19] [20] [21] [22] , advanced maternal age [23] , reduced ovarian reserve [24, 25] , and polycystic ovary syndrome [26] all similarly perturb mitochondrial function in oocytes and resultant embryos.
The direct link between mitochondrial function and embryo development and viability has been established in rodents through pharmacological inhibition of the malate aspartate shuttle (MAS), a necessary component of the tricarboxylic acid cycle and ATP generation in the mitochondria [27, 28] . While precompacting embryos cultured in the presence of pharmacological inhibition of MAS showed some developmental plasticity enabling normal blastocyst development, the quality of these blastocysts was vastly reduced, with impaired blastocyst cell numbers (both trophectoderm [TE] and inner cell mass [ICM] ) [27] , resulting in reduced implantation and fetal development rates posttransfer [28] . Most significantly, the phenotypes of the resultant fetuses were altered, with reduced fetal weights on Embryonic Day 18 and altered gene expression in their brains relating to carbohydrate metabolism, neurological development, cellular proliferation and death, and DNA replication, recombination, and repair [29] , providing further evidence for permanent downstream effects of mitochondrial inhibition limited to the preimplantation embryo. In humans, it has also been reported that singleton babies born from IVF are smaller at birth compared to those born from natural conception, although it is difficult to interpret if this is a result of the culture technology and altered embryo metabolism or of the same mechanisms responsible for the subfertility present in the parents [30] . A recent study assessing two different culture formulations containing different levels of key regulatory compounds, which can change early embryo metabolism, produced divergent birth weight curves that differed by approximately 400 g [31] , suggesting that early embryo metabolism and susceptibility to its culture environment can change fetal growth trajectories. However, whether direct inhibition of mitochondrial function during preimplantation embryo development is responsible for perturbation to offspring health in later life is yet to be determined.
Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) is a potent oxidative phosphorylation uncoupler (a protonophore) that collapses the proton gradient in the inner mitochondrial membrane, thus uncoupling the electrontransport chain and thereby decreasing ATP production, which has been used previously to reduce MMP and ATP output in cell lines and the oocyte [32, 33] . At high levels, particularly those greater than 1 lM, exposure of various tissues types, including isolated nerve terminals, pancreatic bcells, and embryonic kidney cells, to FCCP has been demonstrated to completely uncouple mitochondrial metabolism, resulting in increased calcium levels and signaling, decreased intracellular pH (pHi), and increased ROS levels [32, [34] [35] [36] [37] , with the effect being reversible in some cell types after FCCP is removed [32] . In addition, FCCP has been also been used at submicromolar concentrations (10-300 nM) to generate mild uncoupling of mitochondrial oxidative phosphorylation in ventricular myocytes, which results in alterations to oxygen consumption as well as to mitochondrial redox state and availability of substrates [38, 39] . Therefore, we investigated the ability of FCCP to mildly inhibit mitochondria via reducing MMP and ATP production in the precompacting embryo (the period during which the embryo is completely reliant on mitochondrial metabolism for energy production) to determine lasting effects of impaired embryonic mitochondrial function on future offspring development and metabolic syndrome susceptibility.
MATERIALS AND METHODS

Animals
Female Swiss mice (age, 3-4 wk) were superovulated by an i.p. injection of 5 IU of equine chorionic gonadotropin (Folligon; Intervet), followed 44-46 h later by an IP injection of 5 IU of human chorionic gonadotropin (hCG; Pregnyl; Organon). Females were mated overnight with adult Swiss studs and oviducts collected 24 h after hCG injection. Mice were housed under a 12L:12D photoperiod with food and water supplied ad libitum. Animals were treated in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (7th ed., 2004), with the animal ethics committee of the University of Adelaide approving all experiments.
Media Composition/Chemicals
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. G-MOPS Plus (Vitrolife) was used for all handling, and G1 Plus and G2 Plus (both from Vitrolife) were used for sequential embryo culture. All media were presupplemented with 10% human serum albumin (HSA) unless otherwise stated. The FCCP was dissolved in dimethyl sulfoxide (DMSO) and then diluted with G1 Plus to the required concentrations (62.5, 125, 1250, and 12 500 nM), and the same concentration of DMSO (vehicle) was also added to control G1 Plus.
Embryo Culture
Zygotes were denuded from the surrounding cumulus cells with hyaluronidase, and putative zygotes were cultured in groups of 10 in 20 ll of G1 Plus medium with or without FCCP overlaid with paraffin oil (Merck) and cultured for 48 h at 378C, 6% CO 2 , and 5% O 2 . Embryos (culture with or without FCCP) were then transferred to standard G2 Plus medium for a further 48 h. Embryo development was assessed at 20 h for cleavage to the 2-cell stage, at 48 h for 8-cell development, at 80 h for compaction and early blastocyst formation, and at 96 h of culture for blastocyst formation using phase-contrast microscopy.
Differential Staining
As a measure of mitosis and differentiation of Day 5 blastocysts, the total cell number, ICM cell number, and TE cell number were assessed as previously described [40] . Briefly, blastocysts were incubated in 0.5% pronase at 378C to dissolve the zona pellucida before incubation in 10 mM 2,4,6-trinitrobenzenesulfonic acid at 48C for 10 min. Blastocysts were then washed with G-MOPS (no HSA) and transferred to 0.1 mg/ml of antidinitrophenyl bovine serum albumin for 10 min at 378C before being placed in guinea pig serum with propidium iodide for 5 min at 378C. Blastocysts were then counterstained with bisbenzimide in ethanol at 48C overnight. Embryos were washed in 100% ethanol and mounted in a glycerol drop on a glass slide. Analysis was performed under a fluorescent microscope using an ultraviolet filter where ICM appeared blue and TE cells appeared pink.
JC-1 Staining
Mitochondrial membrane potential was determined by staining 8-cell and blastocyst stage embryos with the mitochondrial stain 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazolyl-carbocynanine iodide (JC-1; Molecular Probes, Life Sciences) as previously described [15] . Briefly, embryos were incubated in 1.5 mM JC-1 (in G-MOPS) for 15 min at 378C in the dark and then imaged using confocal microscopy (Eclipse TE2000-E; Nikon) and analyzed using Adobe Photoshop Pro-CS5 software (Adobe Systems Incorporated). By using the channels function, the red/green staining intensity (pixel density) was established using a previously described method [15] adapted from that originally described by Barnett et al. [41] . For 8-cell embryos, measurements were taken from two regions within each cell (cytoplasmic and cortical regions), with three separate readings taken per region for a minimum of three cells per embryo [15] , and the level of staining was then normalized to control cytoplasmic staining. For blastocyst stage embryos, a single image was captured through the central plane of the blastocyst, and the entire blastocyst was analyzed for red/green staining intensity.
ATP Assay
To establish ATP content in 8-cell embryos, an ATP bioluminescent somatic cell assay kit (FLASC, Sigma-Aldrich) was used as described by McPherson et al. [42] . Solutions were prepared as specified by the manufacturer's protocol. A six-point standard curve was created using a POLARstar Galaxy luminometer in conjunction with FLUOstar Galaxy software (both from BMG Labtechnologies). Eight-cell embryos were extracted individually, and luminescence was determined. The ATP levels were calculated from a six-point standard curve (0-12.5 pmol) measured in parallel with each replicate as previously described with r 2 . 0.98 [42] .
Determination of Intracellular Calcium Levels
Intracellular calcium concentrations were determined with a ratiometric analysis using Fura-2-AM calcium-sensitive probe (Molecular Probes) as previously described [43, 44] . Briefly, 8-cell embryos were incubated in 5 lM Fura-2-AM in G-MOPS for 30 min at 378C. Embryos were then washed twice in G-MOPS (no HSA) and immediately analyzed, with fluorescent intensities recorded. Each individual embryo was analyzed for fluorescent intensity using confocal microscopy and the ratio of fluorescence intensities determined for excitation wavelengths of 340 and 380 nm. The largest dynamic range for Ca 2þ -dependent fluorescence signals was then determined by using excitation at 340 nm (ion-bound calcium) and 380 nm (ion-free calcium) with fluorescence intensities detected at approximately 510 nm using ratiometric software (IP-Lab Advanced Image Analysis Software; BD Biosciences ZANDER-FOX ET AL. Bioimaging). This was then expressed as the ratio of bound to free calcium and standardized to control.
Determination of pHi
Intracellular pH was determined using pH-sensitive fluorophore carboxyseminaphthorhodafluor-1 (SNARF-1) [40] . Briefly, 8-cell embryos were placed into 5 lmol of SNARF-1 (esterified derivative; Molecular Probes) in G-MOPS for 30 min at 378C. The embryos were then washed through G-MOPS, placed onto a slide, and imaged using confocal microscopy. Embryonic pHi was determined by excitation at 488 nm, resulting in two separate emissions (one pH sensitive and one pH insensitive). A ratiometric analysis was performed using ratiometric software (IP-Lab Advanced Image Analysis Software). The pHi was then determined using an in situ standard curve calibration as previously described [40] where the mean regression for the standard curve was r 2 . 0.99.
Vitrification/Warming
Blastocysts were cryopreserved to enable efficient transfer to pseudopregnant recipients. RapidVit Blast along with the Rapid-i Vitrification straws (both from Vitrolife) were used for vitrification of Day 5 blastocysts per the manufacturer's instructions. Briefly, blastocysts were transferred from G-MOPS Plus into Vitri1 Blast for 5 min at 378C, then into Vitri2 Blast for 2 min at 378C, and then into Vitri3 Blast for 35-45 sec at 378C before being placed onto the inner straw in groups of 6-10, inserted into the precooled external straw, sealed, and placed into liquid nitrogen storage. The morning of embryo transfer, blastocysts were warmed by removing the top of the straw and plunging the Rapid-i insert, containing the vitrified blastocysts, into Warm1 Cleave (Vitrolife). After 10-30 sec, the blastocysts were moved into Warm2 Cleave for 1 min, into Warm3 Cleave for 2 min, and then into Warm4 Cleave for 5 min, at which point they were finally moved into a preequilibrated G2 Plus dish and cultured for 3-4 h in G2 Plus before transfer to confirm survival and re-expansion.
Embryo Transfer and Pregnancy
Pseudopregnant female Swiss mice (age, 7-8 wk) were used as recipient mothers for embryo transfer. Females were mated with vasectomized adult Swiss males to induce pseudopregnancy. Females were anesthetized on Day 3.5 of pseudopregnancy with 2% Avertin (0.015 ml/g). Five expanded or hatching blastocysts from the control or FCCP-treated group were transferred to each contralateral uterine horn. Each recipient received only control or FCCP-treated embryos to enable tracking after birth. On Day 18 of pregnancy, mice were housed individually and monitored daily for live birth. Pregnancy rates were calculated as the number of viable progeny as a proportion of the total number of embryos transferred. Date of birth, litter size, and pup survival were recorded. On Postnatal Day 5, pups were weighed and paw tattooed to enable weight to be tracked for individual animals. All animals were again weighed on Postnatal Days 7, 10, 14, and 21. At Postnatal Day 21, offspring were weaned, sexed, ear tagged, and group housed with five animals per sex independent of treatment to control for postweaning exposures. Mice were weighed weekly until 14 wk of age.
Glucose Tolerance Test and Insulin Tolerance Test
At 8 and 14 wk of age, offspring underwent glucose tolerance testing (GTT) and insulin tolerance testing (ITT) to evaluate glucose regulation. For GTT, mice were fasted for 6 h before testing, and a fasting blood glucose reading was determined using a HemoCue 201 RT Analyzer (HemoCue). Mice then received an i.p. injection of 2 g/kg of glucose, and blood glucose levels were monitored and recorded at 15, 30, 60, and 120 min after glucose bolus. GTT data were collated for a summary measure per animal via area under the curve (AUC) analysis. For ITT, fed baseline blood glucose readings were taken 5 min apart, and an i.p. injection of insulin (1.0 IU for males and 0.75 IU for females) was given. Blood glucose readings were taken and recorded at 15, 30, 60, and 120 min after insulin injection. ITT data were assessed per animal by means of area above the curve (AAC).
Dual Energy X-Ray Absorptiometry Body Composition Analysis
Dual energy x-ray absorptiometry (DEXA) was used to determine premortem body composition and adiposity. Mice were fasted for 4 h before DEXA analysis to ensure no calcified food would interfere with x-ray absorption. The mice were anesthetized using 2% Avertin (0.015 ml/g). Using the LUNAR PIXImus densitometer in conjunction with the PIXImus software (version 1.4x; GE Medical Systems), x-ray images were taken of the mice, and bone density, bone mass, lean mass, fat mass, and their respective percentages were determined.
Postmortem Body Composition and Blood Analysis
At 14 wk of age, mice were fasted overnight and anesthetized with Isoflurane (2%; Veterinary Companies of Australia). Blood samples were then collected via cardiac puncture for measurements of metabolic state. Mice were euthenized via cervical dislocation while anesthetized after cardiac puncture was completed. Organs, muscles, and adipose tissues were dissected postmortem and weighed. Serum glucose, cholesterol, nonessential fatty acids, triglycerides, and high-density lipoprotein (HDL) were analyzed using a multianalyte analyzer (Cobas Integra 400; Roche Diagnostics). Blood serum insulin concentrations were measured by the Sensitive Rat Insulin immunoassay (Millipore).
Statistical Analysis
All data are expressed as the mean 6 SEM, with a minimum significance level of P , 0.05. Embryo development (binomial data) was assessed using Fisher exact test. Embryo measures (differential stain, MMP, ATP, Ca 2þ , and pHi) were analyzed by a univariate generalized linear model with least-significant-difference post hoc test. For assessment of offspring measures, data were analyzed by a linear mixed effects model (nonrepeatable) or ANOVA (repeated measures). Mother was included as a random effect to control for variation induced by the mother, and litter size was included as a fixed factor to control for offspring born from the same mother and differences between litter sizes. All offspring were included in the analysis (1-2 offspring/sex/litter). Differences between treatments were determined by Bonferroni post hoc test. All statistical analysis were performed in GraphPad Prism (GraphPad Software) or SPSS (version 12.0.1; SPSS, Inc.) software.
RESULTS
FCCP Does Not Alter Embryo Development at Low Doses but Arrests Development at High Doses
We performed a dose-response experiment using increasing concentrations of FCCP in culture media for the first 48 h (62.5, 125, 1250, and 12 500 nM FCCP in G1 Plus). This time period was chosen because during precompaction, the embryo is primarily reliant on mitochondrial metabolism for ATP generation [10, 12] . These data were then used to subsequently determine an optimum concentration of FCCP that decreased ATP levels yet still permitted viable blastocyst development. High concentrations of FCCP (1250 and 12 500 nM) completely arrested embryo development, lysing embryos within the first 22 h (data not shown). In contrast, culturing with either 62.5 or 125 nM FCCP did not affect blastocyst development on Days 3, 4, or 5 (Supplemental Table S1 ; Supplemental Data are available online at www. biolreprod.org), with a similar percentage developing to the expanded/hatching blastocyst stage after 96 h of culture (control, 69.0%; 62.5 nM, 66.2%; 125 nM, 64.2%; P . 0.05).
FCCP Reduces MMP and ATP Content in 8-Cell Embryos
Levels of MMP in blastomere cytoplasmic regions were significantly reduced in 8-cell embryos in a dose-dependent manner after culturing with 62.5 or 125 nM FCCP compared to control embryos (P , 0.05) (Fig. 1) . Additionally, treatment with 125 nM FCCP also resulted in a significant decrease in the cortical region compared with control (P , 0.05) (Fig. 1) ; however, this decrease was not observed in embryos cultured in 62.5 nM FCCP.
To confirm whether FCCP affected oxidative phosphorylation and thus reduced ATP output, the ATP content of 8-cell EMBRYO MITOCHONDRIAL FUNCTION AND LOW BIRTH WEIGHT embryos was assessed. A significant decrease of ATP levels was found in 8-cell embryos cultured in 62.5 or 125 nM FCCP compared with control embryos (P , 0.05) (Fig. 2) .
FCCP Alters Blastocyst Cell Number and Allocation
No significant differences were found in blastocyst total cell number or TE cell number after exposure to 62.5 nM FCCP compared to control (P . 0.05) (Fig. 3, A and B) . However, exposure to 125 nM FCCP significantly decreased total cell number and ICM cell number compared to control (P , 0.05) (Fig. 3C) , although no significant change to the ICM as a proportion of total cell number was found (Fig.  3D) .
FCCP Alters Calcium Levels and pHi in 8-Cell Embryos
Incubation of embryos with 125 nM FCCP resulted in a significant increase in free intracellular calcium, which in turn resulted in an overall decrease in the bound:free ratio compared to control (0.973 6 0.007 and 0.930 6 0.009, respectively; P , 0.05; control, n ¼ 11; FCCP, n ¼ 12). In addition, incubation with 125 nM FCCP also resulted in a significant decrease in pHi at the 8-cell stage compared to control (7.13 6 0.01 and 7.27 6 0.01, respectively; P , 0.05; control, n ¼ 10; FCCP, n ¼ 10).
Reversibility of FCCP Uncoupling
To assess if exposure to FCCP results in a persistent change to MMP and ATP levels, embryos were removed from FCCP at the 8-cell stage and grown in control culture media to the blastocyst stage before assessment of MMP and ATP levels. The results indicate that exposure to 125 nM FCCP during the cleavage stages before placement into control culture conditions resulted in reversible uncoupling of oxidative phosphorylation, with no change in MMP seen between control and FCCP-treated blastocysts (100.0 6 2.5 and 100.6 6 5.9, respectively; P . 0.05; control, n ¼ 27; FCCP, n ¼ 25) and no significant change seen between ATP levels per cell in control versus FCCP blastocysts (14.2 6 2.2 and 13.3.0 6 1.7 fmol/ cell/blastocyst, respectively; P . 0.05; control, n ¼ 7; FCCP, n ¼ 10).
Selection of FCCP Dose for Offspring Studies
Overall, preimplantation embryo development was not different in both 62.5 and 125 nM FCCP treatments compared to controls, with a similar reduction observed for ICM cell number and ATP concentration at both concentrations. However, given a dose-dependent response in cytoplasmic MMP and, additionally, cortical decreases in MMP in the 125 nM FCCP treatment, that concentration of FFCP was further used to investigate pregnancy and offspring outcomes. were not different between treatments (P . 0.05). However, 125 nM FCCP induced small-at-birth female offspring, a difference that persisted until weaning (P , 0.05) (Fig. 4A) ; this resulted in postweaning ''catchup'' growth such that no differences in body weights were found between 4 and 14 wk of age (P . 0.05) (Fig. 4C) . This small-at-birth phenotype was not observed in male offspring, with no changes to preweaning or postweaning body weights found between treatments (P . 0.05) (Fig. 4, B and D) .
FCCP (125 nM) Increased Adiposity Accumulation in Female Offspring
Female offspring produced from FCCP-treated embryos had smaller adiposity deposits at 4 wk of age both in absolute terms and in proportion of total body weight, with significantly less bone mass as a percentage, consistent with their small-at-birth phenotype (P , 0.05) ( Table 1) . Strikingly, coinciding with their catchup growth, female offspring produced from FCCP-treated embryos gained significantly more adipose tissue over the next 10 wk (P , 0.05) ( Table 1 ), indicating that this catchup growth was likely through increased adipose accumulation. Postmortem dissection at 14 wk of age showed no differences in body composition in regards to organ weight between the treatment groups (Supplemental Table S2) .
Similarly, at 4 wk of age, male offspring produced from FCCP-treated embryos had reduced fat mass both in absolute terms and as a percentage of total body weight (P , 0.05) 
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( Table 2 ). This difference dissipated by 8 wk of age and then remained the same until 14 wk of age (P . 0.05) ( Table 2) . At the 14-wk postmortem, no differences in organ weight were found between the treatment groups (Supplemental Table S3 ).
FCCP (125 nM) Induces Glucose Intolerance and Insulin Resistance in Female Offspring
Female offspring produced from FCCP-treated embryos had reduced glucose tolerance at 8 wk of age, as indicated by an increased AUC compared with offspring derived from control embryos (P , 0.05) (Fig. 5A) . By 14 wk of age, this glucose intolerance was no longer evident (P . 0.05) (Fig. 5A) , with normal fasting insulin levels found (Table 3) ; however, female mice still showed signs of metabolic syndrome with elevated fasted glucose levels (P , 0.05) ( Table 3 ) and insulin resistance, as indicated by a decreased AAC in response to an insulin bolus compared with female offspring derived from control embryos (P , 0.05) (Fig. 5C ). Serum triglycerides were also elevated in female offspring produced from FCCPtreated embryos, which is consistent with an increased adipose state and insulin resistance [45] , and total cholesterol levels were increased as well (P , 0.05) ( Table 3) .
FCCP (125 nM) Induces Glucose Intolerance Without Altering Insulin Sensitivity in Male Offspring
Male offspring produced from FCCP-treated embryos showed no effect of FFCP treatment on glucose or insulin tolerance at 8 wk of age compared with controls (P . 0.05) (Fig. 5, B and D) . However, by 14 wk of age, male offspring derived from FCCP-treated embryos displayed increased fasting serum glucose (P , 0.05) ( Table 4) and were glucose intolerant, as indicated by an increased AUC (P , 0.05) (Fig.  5B) , although again, no measurable change in insulin tolerance could be found (P . 0.05) (Fig. 5D) . Interestingly, male offspring derived from FCCP-treated embryos had reduced levels of serum HDL (P , 0.05) ( Table 4 ), indicating that they might be at higher risk of developing heart disease later in life [46] despite having no difference in total cholesterol (P . 0.05) ( Table 4) .
DISCUSSION
Regulation of metabolic activity in the preimplantation embryo is related to embryo viability [47, 48] , with metabolic activity and ATP levels in the oocyte and early embryo reflective of embryo developmental potential [49] . Furthermore, environmental stressors, such as obesity, advanced maternal age, and high-or low-protein diet [15, 17, 50] , as well as in vitro-derived stresses, such as oxygen concentration and medium composition, perturb early embryo metabolism and reduce embryo developmental competence [7] [8] [9] [10] [11] [12] . This has been shown in both animal models and humans [51, 52] . However, the direct link of altered early embryonic mitochondrial function to impaired developmental programming and offspring phenotype is still unknown. The present study confirms previous findings that inducing mitochondrial EMBRYO MITOCHONDRIAL FUNCTION AND LOW BIRTH WEIGHT dysfunction in precompacting embryos alters embryo development, but it also demonstrates a functional link between early embryonic mitochondrial function and programming of offspring metabolic disease.
An oxidative phosphorylation uncoupler, FCCP has been demonstrated to reduce MMP and ATP output in tissues, cell lines, and oocytes [32, 33] . In addition, this disruption to mitochondrial function also can have downstream effects on calcium levels, pHi, and ROS generation [32, 34, 36] , which in turn may further impact cellular signaling and viability. The early precompaction stage embryo is highly reliant on mitochondrial metabolism for the generation of energy, and this stage of development has been demonstrated to be the most sensitive window for an in vitro-derived stress, with impairments to embryo viability and fetal development even after the stress has been removed [10, 12] . Therefore, this time period was chosen for the present study. It has previously been shown that the direct inhibition of mitochondrial function during this window of development results in reduced blastocyst cell number and allocation and in reduced fetal development at Embryonic Day 18 in mice [27, 28] . Similarly, in the present study, FCCP significantly decreased MMP and ATP content in the 8-cell embryo by approximately 30%, without altering the ability of the embryos to develop to the blastocyst stage. This is consistent with many models that demonstrate the capacity to develop into a blastocyst is not predictive of subsequent viability [10, 53] . Additionally, inhibition of mitochondrial function by 125 nM FCCP decreased total cell number within the blastocysts and reduced ICM cell number. In previous studies, altering mitochondrial function via inhibition of mitochondrial shuttle activity or via suboptimal culture conditions resulted in blastocysts with reduced ICM cell number, giving rise to fetuses with significantly lower fetal weights compared to those derived from normal, untreated blastocysts [27, 28, 53] . In the present study, female offspring produced from embryos cultured with 125 nM FCCP during precompaction were significantly smaller on Postnatal Day 5 and remained on this smaller growth trajectory until weaning. However, by 5 wk of age, the FCCP and control offspring were of similar weight, indicating an accelerated growth pattern between 3 and 5 wk of development. It is well established that offspring with small fetal size for gestational age have an increased susceptibility to chronic disease later in life, including increased risk of metabolic syndrome and cardiovascular disease [54] , and that this risk is exacerbated by accelerated catchup growth [55, 56] .
In the present study, inhibition of metabolic output via FCCP in the precompacting embryo resulted in metabolic dysfunction in both female and male offspring, with phenotypic exacerbation seen in the females. Females displayed less adipose content at 4 wk of age, consistent with their small size; however, as they aged, they accumulated more adiposity, which coincided with their increasing weight gain in this period. This increase in adipose tissue coinciding with catchup ZANDER-FOX ET AL. Different letters indicate a significant difference between distinct time points (P , 0.05).
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growth is consistent with the results of many studies of smallfor-gestational-age children (as determined by a child being in the 10th percentile of a population-specific birth weight or two SD below the mean birth weight for that particular gestational period) [54, 56] and has also been demonstrated for mouse embryos where NADPH and FADþ levels are manipulated in the pronuclear stage [57] . In these studies, offspring also displayed changes to glucose homeostasis, insulin resistance, and lipid metabolism; however, whether this resulted from increased adiposity accumulation with age, or vice versa, remains to be elucidated [58] [59] [60] [61] [62] [63] . Similarly, female offspring produced from FCCP-treated embryos also displayed signs of metabolic syndrome likely mediated through insulin resistance and perturbed adipose function indicating increased risk for development of type II diabetes and cardiovascular disease later in life. Similar metabolic effects in female offspring have been described in other models of small for gestational age, including models of placental insufficiency [64] [65] [66] [67] [68] [69] . This is of interest as the cells within the blastocyst that are most reliant on oxidative metabolism and will ultimately form the placenta are TE cells [70] , so perturbed mitochondrial metabolism may be of higher consequence to the TE cell lineage; however, this remains to be investigated. Therefore, the similarity between offspring phenotypes in our model and others perhaps suggests some impairment to implantation and TE invasion that subsequently may negatively impact placental function and transport, thus reducing fetal size. A previous study [27] on mitochondrial inhibition during the same precompacting stage found reduced placental size, which may also be the case in our model of FCCP inhibition; however, this remains to be confirmed as placental size was unable to be determined in that study. Interestingly, a different and less prominent metabolic effect was seen in male offspring produced from FCCP-treated embryos, with impairments to glucose homeostasis and intolerance to glucose at 14 wk of age despite no signs of insulin resistance. Whether this intolerance results from impaired pancreatic insulin secretion or pancreatic islet cell dysfunction is unknown; however, coupled with the reduced serum HDL concentrations, it may perhaps be indicative of a later onset of metabolic disease. Sexual dimorphism has been reported in a number of maternal/paternal developmental programming environmental stressors [71] [72] [73] [74] . Theories surrounding the observed difference in phenotype between males and females suggest that these differences may result from a combination of sex-specific genetics/epigenetics (i.e., XX female, XY male), interaction with sex-specific steroid hormones, or placenta-based sex-specific responses in utero. Given that female embryos have a greater uptake of glucose during preimplantation embryo development [75, 76] , which indicates a greater energy requirement, we speculate that a reduction to energy production at this stage by FCCP exacerbates the phenotypic effects in this sex.
We have shown that exposure to FCCP, which alters mitochondrial homeostasis and energy production, induces permanent changes to the resultant embryo and offspring even when this perturbation is restricted to the precompaction stage embryo. One mediator for these offspring phenotypes could be through changes to the epigenetic marks within the embryo. During the precompaction stage, significant epigenetic remodeling occurs. After fertilization, both the paternal and maternal genome undergo reprogramming to erase the majority of the gametes' methylation marks, resetting the zygote for totipotency and later establishment of independent epigenetic marks [77] . These remodeling processes rely on ATP supplied by the embryo's mitochondria; for example, the changes in methylation, in particular via the TET proteins, use intermediates of the tricarboxylic acid cycle as substrates for activity [78, 79] . This, therefore, provides a putative link between mitochondrial function and epigenetic regulation, so we speculate that mild impairments to mitochondrial function may result in an energy deficit that is insufficient to support this remodeling process, resulting in alterations to epigenetics of the embryo programming downstream offspring phenotypes. This could also explain why we see such dysmorphic changes between offspring phenotypes of female and males, given the greater energy requirements of female embryos, which have been speculated to be due to X chromosome inactivation [75] . Reduced mitochondrial ATP would likely have a bigger effect, presumably resulting from aberrant expression of developmentally sensitive genes. The specific epigenetic mechanisms involved, however, and which individual loci are involved remain to be determined.
Mitochondrial ATP production is not the only cellular pathway that is disrupted by FCCP exposure. In other tissues, the disruption to MMP and the uncoupling process result in downstream effects to other important mitochondrial processes, such as calcium homeostasis, regulation of pHi, and production of ROS levels, all of which may play a role in altering offspring programming. Exposure to FCCP has been linked to alterations in calcium levels due to its action on Na þ homeostasis [34] , where pancreatic b-cells exposed to FCCP had mobilized intracellular Ca 2þ stores and prolonged Ca 2þ transients suggestive of impaired calcium handling [35] . The regulation of calcium levels is of great importance to normal cell function as well as apoptosis/necrosis [80] and, in the oocyte and embryo, is linked to a variety of important cellular processes, such as completion of meiosis, fertilization, cell signaling, and cell division [81] . In the present study, we have demonstrated a similar outcome where exposure of the cleavage stage embryo to FCCP resulted in increased levels of free calcium within the cytoplasm and changes to the ratio of bound to free calcium. It is therefore possible that the partial collapse of the mitochondrial membrane within the embryo has altered Na þ homeostasis, which in turn alters mitochondrial Ca 2þ regulation within the embryo. Increased levels of free Ca 2þ may in turn change Ca 2þ signaling, which may also contribute to the alterations seen in offspring phenotype. In addition, the alterations in Na þ have also been coupled with an increase in the intracellular proton levels (H þ ), which in nerve cells has been linked to a drop in pHi, and in neuronal cells, FCCP exposure increases ROS production [32, 34, 36] . In the present study, exposure of cleavage stage embryos to FCCP resulted in a significant decrease in pHi, which may also contribute to changes in offspring programming, especially given that pHi is critical for most cellular pathways within the embryos, including metabolism, cell division, cell death, enzymatic activity, calcium levels, and arrangement of the cytoskeleton [82] and unable to be controlled due to the fact that the early embryo has limited ability to regulate pHi [40, 83] . Taken together, these results indicate that further investigation is warranted to ascertain which specific pathway is responsible for influencing offspring programming. Interestingly, it should also be noted that in other models of environmental perturbation, such as maternal high-or low-protein diet or obesity induced by a high-fat diet, where mitochondrial metabolism is perturbed (as evidenced by decreased ATP levels and decreased MMP), the embryos also have altered calcium levels as well as increased ROS levels [15, 18, 84, 85] . Therefore, it could be hypothesized that mitochondrial dysfunction (as a result of either direct perturbation or environmental stress) results in alterations to multiple pathways, which either individually or in unison can program changes in the offspring as offspring from a high-or lowprotein diet have an altered phenotype as well as changes to epigenetic tissue markers [86, 87] .
In conclusion, the data in the present study demonstrate a negative impact of reduced mitochondrial function in the early embryo on subsequent offspring phenotype. Exposure of the early embryo to FCCP, which decreases ATP output by approximately 30%, results in small-at-birth female offspring with increased adipose accumulation and insulin resistance and the beginning of glucose intolerance and increased risk of metabolic syndrome in male offspring. This is of great significance as a larger number of women entering pregnancy are overweight/obese, of advanced age, or have low ovarian reserve, all of which can induce mitochondrial dysfunction in oocytes and subsequent embryos. These observations implicate metabolic health and, particularly, mitochondrial function (both ATP production as well as its role in cellular homeostasis) as a causative pathway in embryo viability and the establishment of lifelong offspring health; however, the direct mitochondrially EMBRYO MITOCHONDRIAL FUNCTION AND LOW BIRTH WEIGHT mediated epigenetic change within the developing embryo still remains to be determined.
